| Anaemia | Blood and lymphatic system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0012 affected356 at risk
|
| Microcytic anaemia | Blood and lymphatic system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Splenomegaly | Blood and lymphatic system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Acute coronary syndrome | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Acute myocardial infarction | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0015 affected356 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0011 affected356 at risk
|
| Bradycardia | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Congestive cardiomyopathy | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Coronary artery disease | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0003 affected356 at risk
- EG0014 affected356 at risk
|
| Coronary artery stenosis | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Extrasystoles | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0010 affected356 at risk
|
| Myocardial infarction | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0010 affected356 at risk
|
| Sinus node dysfunction | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Stress cardiomyopathy | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Systolic dysfunction | Cardiac disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Hydrocele | Congenital, familial and genetic disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Goitre | Endocrine disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Amaurosis fugax | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Angle closure glaucoma | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Cataract | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Detachment of macular retinal pigment epithelium | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Ectropion | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Eye haemorrhage | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Glaucoma | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Iridocyclitis | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Ocular hypertension | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Retinal haemorrhage | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Retinal pigment epithelial tear | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Ulcerative keratitis | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Vitreous adhesions | Eye disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0013 affected356 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Duodenitis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0012 affected356 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Intestinal polyp | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Pancreatitis | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Portal hypertensive gastropathy | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Subileus | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Varices oesophageal | Gastrointestinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Asthenia | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Gait disturbance | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| General physical health deterioration | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Malaise | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Medical device site joint pain | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Multiple organ dysfunction syndrome | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Sudden death | General disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Bile duct stone | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Cholangitis | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0010 affected356 at risk
|
| Cholecystitis acute | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Cholestasis | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Hepatic cirrhosis | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Portal hypertension | Hepatobiliary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Abscess oral | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Bronchitis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Cystitis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Diverticulitis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Endophthalmitis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Erysipelas | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Escherichia sepsis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Gastroenteritis norovirus | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Gastrointestinal infection | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Infectious pleural effusion | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Klebsiella sepsis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Lip infection | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Liver abscess | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Pneumonia | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0014 affected356 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Urosepsis | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Wound infection | Infections and infestations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Acetabulum fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Alcohol poisoning | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Concussion | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0013 affected356 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Hand fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Hip fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0010 affected356 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Pubis fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0013 affected356 at risk
|
| Spinal fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Sternal fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Thoracic vertebral fracture | Injury, poisoning and procedural complications | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Body temperature decreased | Investigations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Intraocular pressure increased | Investigations | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0013 affected356 at risk
|
| Fluid retention | Metabolism and nutrition disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0013 affected356 at risk
|
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0013 affected356 at risk
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0004 affected356 at risk
- EG0011 affected356 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0012 affected356 at risk
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Bladder cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Gastrointestinal stromal tumour | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Non-small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Penile cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0011 affected356 at risk
|
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Akinesia | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Aphasia | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Brain stem stroke | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Carotid artery stenosis | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0003 affected356 at risk
- EG0010 affected356 at risk
|
| Cerebellar infarction | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Cerebral haemorrhage | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0003 affected356 at risk
- EG0013 affected356 at risk
|
| Cervical myelopathy | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Dizziness | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Formication | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Glossopharyngeal neuralgia | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Hyperkinesia | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Lacunar infarction | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Parkinson's disease | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Peripheral sensorimotor neuropathy | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0011 affected356 at risk
|
| Syncope | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0012 affected356 at risk
|
| Transient ischaemic attack | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0002 affected356 at risk
- EG0012 affected356 at risk
|
| Vascular dementia | Nervous system disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Device breakage | Product Issues | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Emotional distress | Psychiatric disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Chronic kidney disease | Renal and urinary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Nephrolithiasis | Renal and urinary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Urethral dilatation | Renal and urinary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Atrophic vulvovaginitis | Reproductive system and breast disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Drug eruption | Skin and subcutaneous tissue disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Aortic aneurysm | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Arteriosclerosis | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0012 affected356 at risk
|
| Hypertension | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0012 affected356 at risk
|
| Hypertensive crisis | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0004 affected356 at risk
- EG0011 affected356 at risk
|
| Lymphoedema | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0000 affected356 at risk
- EG0011 affected356 at risk
|
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA (17.1) | Systematic Assessment | | - EG0001 affected356 at risk
- EG0010 affected356 at risk
|